Community pharmacists’ roles during the closure stage of the COVID-19 pandemic in Newfoundland and Labrador, Canada: a qualitative case study

• Published in: BMJ Open
• Main Authors: Farooq, Sylvia, Donnan, Jennifer R, Lukewich, Julia, Mathews, Maria, Lee, Tiffany A
• Other Authors: Memorial University of Newfoundland
• Format: Article in Journal/Newspaper
• Language: English
• Published: BMJ 2024
• Subjects: Newfoundland
• Online Access: http://dx.doi.org/10.1136/bmjopen-2024-085338; https://syndication.highwire.org/content/doi/10.1136/bmjopen-2024-085338

Objectives To explore the experiences and perspectives of community pharmacists regarding their roles during the closure stage (ie, March to May 2020) of the COVID-19 pandemic in Newfoundland and Labrador (NL), Canada. Design This qualitative case study included a document analysis and semistructured interviews with community pharmacists who provided direct patient care during the COVID-19 pandemic. The document analysis was used to develop a chronology that informed the interviews. Themes from qualitative interviews were developed through iterative cycles of data review and analysis using applied thematic analysis. Findings are presented specifically for the time period between March and May 2020, defined as the ‘Closure Stage’. Setting Community pharmacies in NL, Canada. Results 12 community pharmacists participated in the interviews. Four themes were developed including (1) pharmacists’ leadership in continuity of care, (2) pharmacists as medication stewards, (3) pharmacists as a source of COVID-19 health information and (4) the impact of COVID-19 on pharmacists’ mental health and well-being. The first three themes described the key roles played by community pharmacists during the early days of the COVID-19 pandemic, including coordinating care, prescribing for common ailments, delivering medications and supplies, providing information on COVID-19 symptoms and their management, renewing chronic medications and protecting the medication supply. Unclear guidance on scope of practice, limited scope of practice, inadequate staffing and limited support from government bodies were identified as barriers to these roles. Facilitators included access to a delivery service, swift regulatory changes, reimbursement and support from colleagues and other healthcare professionals. The fourth theme is presented independently, emphasising the impact of working within the primary healthcare (PHC) system during the COVID-19 pandemic on pharmacists’ mental health and well-being. Conclusion Pharmacists played a critical role in ...